A chemical screen for medulloblastoma identifies quercetin as a putative radiosensitizer

A chemical screen for medulloblastoma identifies quercetin as a putative radiosensitizer

Treatment of medulloblastoma in children fails in approximately 30% of patients, and is often accompanied by severe late sequelae. Therefore, more effective drugs are needed that spare normal tissue and diminish long-term side effects. Since radiotherapy plays a pivotal role in the treatment of medu...

Full description

Bibliographic Details
Main Authors: Lagerweij, Tonny, Hiddingh, Lotte, Biesmans, Dennis, Crommentuijn, Matheus H.W., Cloos, Jacqueline, Li, Xiao-Nan, Kogiso, Mari, Tannous, Bakhos A., Vandertop, W. Peter, Noske, David P., Kaspers, Gertjan J.L., Würdinger, Tom, Hulleman, Esther
Format: Online
Language:English
Published: Impact Journals LLC 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094961/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094961/

Similar Items